Jubilant Cadista recalls 4mg methylprednisolone tablets due to subpotent content. This may affect medication effectiveness. Check NDC 59746-0:001-06 or lot #21P0322 for affected products.
“Jubilant Cadista Methylprednisolone Tablets 4mg Recall: Subpotent Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35021-jubilant-cadista-methylprednisolone-tablets-4mg-recall-subpotent-risk. Based on FDA recall #D-0752-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0752-2022%22&limit=1).
The FDA announced on April 1, 2022, that Jubilant Cadista Pharmaceuticals recalled Methylprednisolone Tablets USP 4mg due to subpotency risks. The voluntary Class III recall affects 19,222 bottles distributed nationwide.
The recall was initiated because the Methylprednisolone Tablets were found to be subpotent. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Jubilant Cadista Pharmaceuticals has had 24 other recalls since February 11, 2013. Recent brand recalls include a December 27, 2022 subpotent drug risk for Prochlorperazine Tablets and a July 18, 2022 recall of Irbesartan tablets due to failed dissolution specifications. Other recent recalls of similar products include Unichem busPIRone 5mg Tablets (April 13, 2026), Major Pharmaceuticals Levothyroxine Tablets (July 13, 2026), and Accord Healthcare Levothyroxine Tablets (August 6, 2026).
How to tell if you have this one
Check for the NDC code 59746-001-06 or lot number 21P0322 on the product packaging. The product is a 100-count bottle sold by prescription only.
Brand
Jubilant Cadista
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the NDC code 59746-001-06 or lot number 21P0322 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0752-2022 (April 1, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0752-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.